Literature DB >> 20082159

High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis.

Yuki Kagoya, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20082159     DOI： 10.1007/s12185-009-0485-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

Review 1.  Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Authors:  Ralf D Hess
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Severe neutropenia in infectious mononucleosis.

Authors:  W P Hammond; J M Harlan; S E Steinberg
Journal:  West J Med       Date:  1979-08

3.  Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis.

Authors:  Tohru Takahashi; Nanaka Hamasaka; Sayaka Harada; Nobuaki Sugawara; Mitsuru Yoshimoto
Journal:  Am J Hematol       Date:  2007-05       Impact factor: 10.047

4.  Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

Authors:  Yunfeng Cheng; Raymond S M Wong; Yannie O Y Soo; Chung Hin Chui; Fung Yi Lau; Natalie P H Chan; Wai Shan Wong; Gregory Cheng
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

5.  Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis.

Authors:  E M Cyran; J M Rowe; R E Bloom
Journal:  Am J Hematol       Date:  1991-10       Impact factor: 10.047

6.  Acute Epstein-Barr virus infection complicated by severe thrombocytopenia.

Authors:  M L Pipp; N D Means; J W Sixbey; K L Morris; C L Gue; L M Baddour
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079
  6 in total
  2 in total

Review 1.  Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Authors:  Debora Martorelli; Elena Muraro; Anna Merlo; Riccardo Turrini; Damiana Antonia Faè; Antonio Rosato; Riccardo Dolcetti
Journal:  Clin Dev Immunol       Date:  2012-01-29

2.  Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective Study.

Authors:  Jin Hong; Xiaosong Chen; Jiahui Huang; Chunqing Li; Li Zhong; Leying Chen; Jiayi Wu; Ou Huang; Jianrong He; Li Zhu; Weiguo Chen; Yafen Li; Hua Wan; Kunwei Shen
Journal:  Integr Cancer Ther       Date:  2016-11-10       Impact factor: 3.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.